No risk assessment shall be carried out where the new psychoactive substance is at an advanced stage of assessment within the United Nations system, namely once the World Health Organisation Expert Committee on Drug Dependence has published its critical review together with a written recommendation, except where there are sufficient data and information available to suggest the need for a risk assessment report at Union level, the reasons for which shall be indicated in the initial report.
Ní dhéanfar aon mheasúnú riosca sa chás go bhfuil céim i bhfad amach sroichte sa mheasúnú ar an tsubstaint shícighníomhach nua laistigh de chóras na Náisiún Aontaithe, eadhon a luaithe a bheidh Coiste Saineolaithe na hEagraíochta Domhanda Sláinte ar Spleáchas ar Dhrugaí tar éis a athbhreithniú criticiúil, mar aon le moladh i scríbhinn, a fhoilsiú, ach amháin sa chás go bhfuil sonraí leordhóthanacha agus faisnéis leordhóthanach ann chun a thabhairt le tuiscint go bhfuil gá le tuarascáil ar an measúnú riosca ar leibhéal an Aontais, a luafar na cúiseanna atá léi sa tuarascáil tosaigh.